Total Payments
$4,837
2024 Payments
$65.88
Companies
34
Transactions
183
Medicare Patients
920
Medicare Billing
$115,859
Payment Breakdown by Category
Food & Beverage$4,381 (90.6%)
Education$455.88 (9.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,381 | 177 | 90.6% |
| Education | $455.88 | 6 | 9.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,662 | 65 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $437.96 | 18 | $0 (2021) |
| Rigel Pharmaceuticals, Inc. | $319.00 | 3 | $0 (2019) |
| Celgene Corporation | $303.44 | 12 | $0 (2019) |
| Janssen Biotech, Inc. | $251.89 | 16 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $191.62 | 8 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $189.43 | 4 | $0 (2020) |
| Eisai Inc. | $182.47 | 5 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $150.69 | 11 | $0 (2020) |
| PFIZER INC. | $150.48 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.88 | 1 | Regeneron Healthcare Solutions, Inc. ($65.88) |
| 2023 | $21.00 | 1 | PFIZER INC. ($21.00) |
| 2021 | $12.19 | 1 | Novartis Pharmaceuticals Corporation ($12.19) |
| 2020 | $488.16 | 23 | Bayer HealthCare Pharmaceuticals Inc. ($176.66) |
| 2019 | $2,554 | 106 | Amgen Inc. ($971.06) |
| 2018 | $1,363 | 47 | Amgen Inc. ($640.30) |
| 2017 | $332.71 | 4 | Novartis Pharmaceuticals Corporation ($223.08) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $65.88 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2023 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 07/27/2021 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: ONCOLOGY | ||||||
| 03/13/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: ONCOLOGY | ||||||
| 03/06/2020 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Oncology | ||||||
| 03/05/2020 | Amgen Inc. | Neulasta (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Oncology | ||||||
| 03/05/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: ONCOLOGY | ||||||
| 03/03/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2020 | Eisai Inc. | Halaven (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Oncology | ||||||
| 02/20/2020 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Bone Health | ||||||
| 02/19/2020 | Janssen Biotech, Inc. | BALVERSA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Oncology | ||||||
| 02/18/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $154.38 | General |
| Category: Oncology | ||||||
| 02/17/2020 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Oncology | ||||||
| 02/13/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2020 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: ONCOLOGY | ||||||
| 02/11/2020 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: Oncology | ||||||
| 02/06/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2020 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $11.06 | General |
| 01/30/2020 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Oncology | ||||||
| 01/24/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Hematology/Oncology | ||||||
| 01/21/2020 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Oncology | ||||||
| 01/10/2020 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Oncology | ||||||
| 01/09/2020 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2020 | Amgen Inc. | KANJINTI (Biological), MVASI, Neulasta | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 259 | 357 | $88,665 | $33,615 |
| 2022 | 6 | 290 | 403 | $98,349 | $38,483 |
| 2021 | 5 | 271 | 384 | $81,421 | $33,652 |
| 2020 | 4 | 100 | 127 | $29,855 | $10,108 |
Total Patients
920
Total Services
1,271
Medicare Billing
$115,859
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 94 | 170 | $43,182 | $17,248 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 85 | $13,191 | $6,012 | 45.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 32 | 38 | $11,999 | $4,082 | 34.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $13,300 | $3,791 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 21 | $5,223 | $1,536 | 29.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 15 | 15 | $1,770 | $946.40 | 53.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 109 | 204 | $50,226 | $21,929 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 119 | $18,005 | $7,886 | 43.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 40 | 40 | $19,000 | $4,953 | 26.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $8,480 | $2,243 | 26.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 12 | $1,416 | $894.80 | 63.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 13 | $1,222 | $577.25 | 47.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 182 | $27,234 | $13,365 | 49.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 52 | 87 | $20,854 | $9,735 | 46.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 62 | 62 | $28,661 | $8,163 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 40 | $3,652 | $1,765 | 48.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 13 | $1,020 | $624.96 | 61.3% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $13,148 | $3,692 | 28.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 58 | $8,513 | $3,517 | 41.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $5,603 | $1,778 | 31.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 28 | 29 | $2,591 | $1,121 | 43.3% |
About Dr. Shruti Bhandari, M.D
Dr. Shruti Bhandari, M.D is a Hematology & Oncology healthcare provider based in Brewer, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2014. The National Provider Identifier (NPI) number assigned to this provider is 1497169650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shruti Bhandari, M.D has received a total of $4,837 in payments from pharmaceutical and medical device companies, with $65.88 received in 2024. These payments were reported across 183 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,381).
As a Medicare-enrolled provider, Bhandari has provided services to 920 Medicare beneficiaries, totaling 1,271 services with total Medicare billing of $115,859. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Brewer, ME
- Active Since 06/16/2014
- Last Updated 10/23/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497169650
Products in Payments
- Neulasta (Biological) $369.02
- Tavalisse (Drug) $319.00
- Nplate (Biological) $283.49
- XGEVA (Biological) $249.01
- Abraxane (Drug) $180.01
- Erleada (Drug) $178.04
- OPDIVO (Biological) $157.96
- Vitrakvi (Drug) $154.38
- Lenvima (Drug) $149.98
- KEYTRUDA (Biological) $139.10
- MEKINIST (Drug) $136.80
- IMFINZI (Drug) $121.51
- SUTENT (Drug) $118.39
- Prolia (Biological) $116.06
- Revlimid (Drug) $110.92
- FOUNDATIONONE (Device) $101.96
- ZYTIGA (Drug) $99.95
- DARZALEX (Biological) $99.80
- LIBTAYO (Biological) $94.83
- Blincyto (Biological) $90.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brewer
Dr. Philip Brooks, Md, MD
Hematology & Oncology — Payments: $5,739
Hematology & Oncology $5,739
Yelena Patsiornik, Md, MD
Hematology & Oncology — Payments: $1,999
Hematology & Oncology $1,999
Thomas Openshaw, Md, MD
Hematology & Oncology — Payments: $1,310
Hematology & Oncology $1,310
Dr. Sigrid Berg, Md, MD
Hematology & Oncology — Payments: $221.02
Hematology & Oncology $221.02
Jens Rueter, Md, MD
Hematology & Oncology — Payments: $218.42
Hematology & Oncology $218.42
Audrey Garrett, Md, MD
Hematology & Oncology — Payments: $173.66
Hematology & Oncology $173.66